DENTSPLY SIRONA (NASDAQ:XRAY) Given New $23.00 Price Target at Needham & Company LLC

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by Needham & Company LLC from $25.00 to $23.00 in a research report sent to investors on Friday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the medical instruments supplier’s stock.

Several other research analysts have also commented on the company. Mizuho assumed coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target on the stock. Wells Fargo & Company assumed coverage on DENTSPLY SIRONA in a research report on Friday, February 14th. They set an “equal weight” rating and a $20.00 price target on the stock. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Tuesday, February 18th. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $23.58.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $16.55 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a fifty-two week low of $16.21 and a fifty-two week high of $34.91. The firm has a market capitalization of $3.29 billion, a PE ratio of -8.00, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The stock’s 50-day simple moving average is $18.88 and its 200-day simple moving average is $21.55.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.87%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently modified their holdings of XRAY. Pacer Advisors Inc. boosted its stake in shares of DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after buying an additional 4,473,972 shares in the last quarter. Nuance Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after buying an additional 2,708,097 shares in the last quarter. Norges Bank purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $45,730,000. AQR Capital Management LLC boosted its position in DENTSPLY SIRONA by 245.1% during the fourth quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier’s stock worth $54,389,000 after purchasing an additional 2,054,767 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in DENTSPLY SIRONA by 18.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after purchasing an additional 1,975,404 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.